Watch Dave Sheppard give the 2026 ODT Forum State of the Industry. This session provides a comprehensive overview of the happenings within the orthopedic device manufacturing industry. Supply chain, M&A, and other related topics critical to both OEMs and their supply partners are covered.
Rewatch our webinar with Today’s Medical Developments as we explore the value impacts of AI in MedTech in 2026 for MedTech companies at all stages of growth – from start-up to scale-up including operational excellence through M&A Exit.
The $75 billion orthopedic market is growing, but pricing pressure throughout the supply chain is intensifying.
With the global environment for medical device manufacturing, cross-border deals are common and may provide for a unique definition for success.
When connected medical devices meet state-sponsored hackers, the C-suite owns the outcome.
Medtech executives or board members with an eye toward a future liquidity event should start building intrinsic value in their respective organizations now.
Understand what drives value in today’s medtech M&A market, from multiples and EBITDA to buyer strategy and deal timing.
The buyers who will set valuations are already asking AI-specific questions during initial conversations.
The lasting impression from AAOS 2026 is that the orthopedic industry is not waiting for the future.
Medtech companies must assess where artificial intelligence creates value at each stage of the product lifecycle.